FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

HR Hendriks

Research Profile

Living Beings

Chemicals & Drugs

Procedures

Anatomy

Concepts & Ideas

Drug Dose Response Relationship

Physiology

Cell Adhesion

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
André Bergman; Auke D Adema; Jan Balzarini; Skjalg Bruheim; Iduna Fichtner; Paul Noordhuis; Oystein Fodstad; F Myhren; ML Sandvold; HR Hendriks; Godefridus J Peters
Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models.
André Bergman; CM Kuiper; F Myhren; ML Sandvold; HR Hendriks; Godefridus J Peters
Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinosylcytosine (ara-C) in leukemia and solid tumor cell lines.
André Bergman; CM Kuiper; Paul Noordhuis; Kees Smid; Daphne Voorn; Elizabeth M Comijn; F Myhren; ML Sandvold; HR Hendriks; O Fodstad; K Breistøl; Godefridus J Peters
Antiproliferative activity and mechanism of action of fatty acid derivatives of gemcitabine in leukemia and solid tumor cell lines and in human xenografts.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of HR Hendriks (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2011: André Bergman; Auke D Adema; Jan Balzarini; Skjalg Bruheim; Iduna Fichtner; Paul Noordhuis; Oystein Fodstad; F Myhren; ML Sandvold; HR Hendriks; Godefridus J Peters
Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models.
Investigational new drugs 2011;29(3):456-66.
2004: André Bergman; CM Kuiper; F Myhren; ML Sandvold; HR Hendriks; Godefridus J Peters
Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinosylcytosine (ara-C) in leukemia and solid tumor cell lines.
Nucleosides, nucleotides & nucleic acids 2004;23(8-9):1523-6.
2004: André Bergman; CM Kuiper; Paul Noordhuis; Kees Smid; Daphne Voorn; Elizabeth M Comijn; F Myhren; ML Sandvold; HR Hendriks; O Fodstad; K Breistøl; Godefridus J Peters
Antiproliferative activity and mechanism of action of fatty acid derivatives of gemcitabine in leukemia and solid tumor cell lines and in human xenografts.
Nucleosides, nucleotides & nucleic acids 2004;23(8-9):1329-33.
2004: Athanasia Varvaresou; Kritonas Iakovou; Evagelos Gikas; Iduna Fichtner; Heinz-Herbert Fiebig; Lloyd R Kelland; John A Double; Michael C Bibby; HR Hendriks
Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
Anticancer research 2004;24(2B):907-19.
2004: André Bergman; CM Kuiper; Daphne Voorn; Elizabeth M Comijn; F Myhren; ML Sandvold; HR Hendriks; Godefridus J Peters
Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.
Biochemical pharmacology 2004;67(3):503-11.
2000: Heinz-Herbert Fiebig; WA Dengler; HR Hendriks
No evidence of tumor growth stimulation in human tumors in vitro following treatment with recombinant human growth hormone.
Anti-cancer drugs 2000;11(8):659-64.
1999: HR Hendriks; Heinz-Herbert Fiebig; Raffaella Giavazzi; S P Langdon; J M Jimeno; Glynn Faircloth
High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(10):1233-40.
1999: K Breistøl; HR Hendriks; Oystein Fodstad
Superior therapeutic efficacy of N-L-leucyl-doxorubicin versus doxorubicin in human melanoma xenografts correlates with higher tumour concentrations of free drug.
European journal of cancer (Oxford, England : 1990) 1999;35(7):1143-9.
1999: Godefridus J Peters; Daphne Voorn; CM Kuiper; Clasina L Van der Wilt; Paul Noordhuis; Kees Smid; F Myhren; ML Sandvold; HR Hendriks
Cell specific cytotoxicity and structure-activity relationship of lipophilic 1-B-D-arabinofuranosylcytosine (ara-C) derivatives.
Nucleosides & nucleotides 1999;18(4-5):877-8.
1998: K Breistøl; HR Hendriks; Dietmar P Berger; S P Langdon; Heinz-Herbert Fiebig; Oystein Fodstad
The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts.
European journal of cancer (Oxford, England : 1990) 1998;34(10):1602-6.
1997: John R Masters; R J Know; John A Hartley; Lloyd R Kelland; HR Hendriks; T Connors
KW-2149 (7-N-[2-[gamma-L-glutamylamino]ethyldithioethyl]mitomycin C). A new mitomycin C analogue activated by serum.
Biochemical pharmacology 1997;53(3):279-85.
1996: M Koufaki; V Polychroniou; T Calogeropoulou; A Tsotinis; M Drees; H H Fiebig; S LeClerc; HR Hendriks; Alexandros Makriyannis
Alkyl and alkoxyethyl antineoplastic phospholipids.
Journal of medicinal chemistry 1996;39(13):2609-14.
1995: M Drees; W M Dengler; HR Hendriks; L R Kelland; Heinz-Herbert Fiebig
Cycloplatam: a novel platinum compound exhibiting a different spectrum of anti-tumour activity to cisplatin.
European journal of cancer (Oxford, England : 1990) 1995;31A(3):356-61.
1994: Simon P Langdon; HR Hendriks; Boudewijn J M Braakhuis; G Pratesi; Dietmar P Berger; Oystein Fodstad; Heinz-Herbert Fiebig; Epie Boven
Preclinical phase II studies in human tumor xenografts: a European multicenter follow-up study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(5):415-22.
1993: HR Hendriks; P E Pizao; Dietmar P Berger; K L Kooistra; M C Bibby; Epie Boven; H C Dreef-van der Meulen; R E Henrar; Heinz-Herbert Fiebig; J A Double
EO9: a novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models.
European journal of cancer (Oxford, England : 1990) 1993;29A(6):897-906.
1992: HR Hendriks; J Plowman; Dietmar P Berger; K D Paull; Heinz-Herbert Fiebig; Oystein Fodstad; H C Dreef-van der Meulen; R E Henrar; HERBERT PINEDO; G Schwartsmann
Preclinical antitumour activity and animal toxicology studies of rhizoxin, a novel tubulin-interacting agent.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(9):755-63.
1992: HR Hendriks; Simon P Langdon; Dietmar P Berger; K Breistøl; Heinz-Herbert Fiebig; Oystein Fodstad; G Schwartsmann
Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenografts.
European journal of cancer (Oxford, England : 1990) 1992;28A(4-5):767-73.
1990: Reina E Mebius; HR Hendriks; J Brevé; Georg Kraal
Macrophages and the activity of high endothelial venules. The effect of interferon-gamma.
European journal of immunology 1990;20(7):1615-8.
1990: Adriaan Duijvestijn; M Rep; HR Hendriks; Georg Kraal
Functional capacities of high endothelial venules appear not to be controlled by recirculating lymphocytes.
Immunobiology 1990;180(4-5):295-307.
1989: HR Hendriks; C Korn; Reina E Mebius; Georg Kraal
Interferon-gamma-increased adherence of lymphocytes to high endothelial venules.
Immunology 1989;68(2):221-6.
1989: Guus A M S van Dongen; Boudewijn J M Braakhuis; A Leyva; HR Hendriks; B B Kipp; M Bagnay; Gordon B Snow
Anti-tumor and differentiation-inducing activity of N,N-dimethylformamide (DMF) in head-and-neck cancer xenografts.
International journal of cancer. Journal international du cancer 1989;43(2):285-92.
1988: Adriaan Duijvestijn; M Rep; E C Butcher; HR Hendriks; Georg Kraal
Regulation of functional and morphological aspects of high endothelium in mouse.
Advances in experimental medicine and biology 1988;237():491-7.
1988: HR Hendriks; C Korn; Adriaan Duijvestijn; Georg Kraal
Changes in lymphocyte binding and expression of His 22 of high endothelial venules in rat lymph nodes after occlusion of afferent lymph flow.
Advances in experimental medicine and biology 1988;237():485-90.
1987: HR Hendriks; Adriaan Duijvestijn; Georg Kraal
Rapid decrease in lymphocyte adherence to high endothelial venules in lymph nodes deprived of afferent lymphatic vessels.
European journal of immunology 1987;17(12):1691-5.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.